期刊
CURRENT OPINION IN IMMUNOLOGY
卷 22, 期 3, 页码 358-366出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2010.02.012
关键词
-
类别
资金
- NIAID
- International AIDS Vaccine Initiative
- Ragon Institute of MGH, MIT, and Harvard
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R37AI055332] Funding Source: NIH RePORTER
Many antiviral vaccines elicit neutralizing antibodies as a correlate of protection. For HIV, given the huge variability of the virus, it is widely believed that the induction of a broadly neutralizing antibody (bNAb) response will be crucial in a successful vaccine against the virus. Unfortunately, despite many efforts, the development of an immunogen that elicits bNAbs remains elusive. However, recent structural studies of HIV-1 Env proteins, generation of novel bNAbs, maturation of technologies for the isolation of further antibodies, insights into the requirements for antibody-mediated protection, and novel vaccination approaches are providing grounds for renewed optimism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据